The clinical significance of urinary fibrinopeptide A and fibrinopeptide B-beta 15-42 in chronic rejection and nephrotoxicity of renal allograft recipients immunosuppressed with cyclosporine.
D003524:Cyclosporins / Q000009:adverse effects*; D005338:Fibrin Fibrinogen Degradation Products / Q000652:urine; D005340:Fibrinogen / Q000652:urine*; D005344:Fibrinopeptide A / Q000652:urine*; D005345:Fibrinopeptide B / Q000652:urine*; D006084:Graft Rejection; D006801:Humans; D007668:Kidney / Q000187:drug effects; D016030:Kidney Transplantation; D010446:Peptide Fragments / Q000652:urine*; D014184:Transplantation, Homologous
D003524:Cyclosporins; D005338:Fibrin Fibrinogen Degradation Products; D010446:Peptide Fragments; C033786:fibrinogen Bbeta (15-42); D005344:Fibrinopeptide A; D005345:Fibrinopeptide B; D005340:Fibrinogen